Sampre Nutritions' record shows seven years of unqualified audit opinions, but the numbers tell a different story: revenue halved and then rebounded, promoter entities are both the company's largest customer and its largest lender, and a going-concern warning was raised after a ₹7.31 crore loss. The board is promoter-dominated, director pay has tripled through the loss, and offshore subsidiaries with nil revenue carry ₹73.67 crore in equity capital.
Key findings
- Promoter entities are both the largest customer and the largest lender
Major- Consolidated trade receivables from related parties rose from ₹6.93 crore in FY2025 to ₹9.55 crore in FY2026. Unsecured loans from directors and relatives reached ₹9.53 crore as at 31 March 2026, up from ₹7.20 crore a year earlier. On 12 December 2025, shareholders approved converting those promoter loans into equity shares on a preferential basis. - Unqualified audit opinions sit alongside a going-concern warning and a contradictory cash-loss statement
Major- The statutory auditor issued unqualified opinions for every year from FY2020 through FY2026. The FY2025 standalone auditor's report included an Emphasis of Matter, a special call-out in the audit report, stating the Company incurred a net loss of ₹7.31 crore, raising significant doubt about its ability to continue as a going concern. The FY2026 CARO report contains contradictory statements: one sentence states the Company "has incurred cash losses during the financial year" and another states it "has not incurred cash losses" for the current year, while confirming cash losses of ₹5.34 crore in the immediately preceding year. - A dormant UK subsidiary holds ₹73.67 crore in equity capital with nil revenue
Major- Sampre Nutritions Holding Limited (UK) held equity share capital of 66,59,000 GBP (₹73.67 crore) as of March 31, 2025, yet reported total revenues of ₹Nil for the year then ended. The Dubai subsidiary, Sampre Nutritions FZCO, had total assets of only ₹7.51 lakhs and the group's share of its net loss was ₹33.77 lakhs for FY25. A receivable of ₹3.86 crore was due from the Dubai subsidiary to the parent company as of March 31, 2025. - Secretarial audit reports flagged non-compliances in three consecutive years
Major- Non-compliance with Regulation 47(1)(a) regarding paper publication and advances to sister concerns in non-compliance with the Companies Act, 2013, were flagged in FY2019-20, FY2020-21, and FY2021-22. The Corporate Governance Report for FY2025-26 states there were no instances of non-compliance, penalties or strictures imposed by stock exchanges during the last three years. - A ₹48.32 lakh FCCB advisory fee was capitalised for over two years then written off
Minor- Professional fees of ₹48.32 lakhs paid to Aries Capital Ltd. during FY2022-23 for FCCB advisory services were initially capitalised under Capital Work-in-Progress and then written off to the Statement of Profit and Loss in FY2024-25. The auditor drew an Emphasis of Matter to this arrangement, noting the fees were capitalised from 29 September 2022 until the write-off. - A Central Excise demand of ₹10.70 lakh has been contested since at least FY2019-20
Minor- Sampre Nutritions has carried a contingent liability for a Central Excise demand order for FY2010-11, quantified at ₹10,70,000, with the dispute pending before CESTAT, Hyderabad and no provision made. The Central Excise demand has been disclosed as a contingent liability with an appeal filed and the company expecting a favourable result in every annual report from FY2019-20 through FY2025-26. - Auditor rotation followed the statutory five-year term with no disclosed disputes
Clean- RRK & Associates served as statutory auditor from FY2019-20 through FY2023-24, completing a five-year term. N G Rao & Associates was appointed for five consecutive years from FY2023-24, with shareholders approving the appointment on 1 December 2024 by 100.00% of votes cast. The outgoing auditor raised no issues, objections or concerns upon the change.
What to watch
- Promoter loan-to-equity conversion. Conversion of promoter unsecured loans into equity shares, as approved by shareholders on 12 December 2025, pending allotment.
- Director remuneration vote. Outcome of shareholder vote at the 35th AGM on the proposal to increase Vishal Ratan Gurbani's remuneration from ₹18,00,000 to ₹60,00,000 per annum effective 1 April 2026.
- CARO cash-loss contradiction. Resolution of the contradictory cash-loss statements in the FY2026 CARO report, which may require a clarification or revised filing from the auditor.
- Going-concern status. Whether the going-concern doubt raised in the FY2025 audit report is resolved or repeated in the FY2027 audit report, given the Company returned to profitability in FY2026.
- Related-party receivable recovery. Recovery of 9.55 crore in trade receivables from related parties outstanding as at 31 March 2026.
Bottom line: This is a disclosed record with seven years of unqualified audit opinions and a return to revenue growth in FY2026. The risk is concentrated in the circular relationship with promoter entities, who are simultaneously the company's largest customer, its largest lender, and its controlling shareholders. The going-concern warning, the contradictory CARO statement, and the tripling of director pay through a loss year all point to governance strain. Watch the loan-to-equity conversion, the recovery of ₹9.55 crore in related-party receivables, and whether the auditor clarifies the cash-loss contradiction.